It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Henry Sobo, MD Holistic & Integrative Medicine, Stamford, Connecticut Peptide Therapy for Weight Loss in Connecticut: AOD-9604, Tesamorelin & Beyond In Stamford and across Connecticut, many patients are asking about peptide therapy as a newer tool for medically supervised weight loss and metabolic health, especially as they hear about options like AOD9604, tesamorelin, and GLP1 medications
From initial contact via the website through to my visit at the clinic, the process with IV Boost London was seamless and well organised
The dose is 1000 mcg (1 mg)